Vanderbilt researchers used pharmacological manipulations to increase salt and water transport by kidney cells grown in culture, a step necessary for realizing an implantable artificial kidney device.

Black men with high blood pressure could benefit from a research study beginning this month to check their vitals while they are getting a haircut at a barbershop.

The Nashville Veterans Affairs Medical Center has dedicated its dialysis unit to William Stone, MD, a nephrologist and professor of Medicine at VUMC

The American Society of Gene and Cell Therapy (ASGCT) has appointed Matthew Wilson, MD, PhD, associate professor of Medicine in Vanderbilt’s Division of Nephrology and Hypertension, to its board of directors. Beginning in May 2019, Wilson will serve a three-year term as an at-large director.

Jun. 28, 2018—T. Alp Ikizler, MD, an internationally known expert on the nutritional and metabolic aspects of kidney disease, will succeed Raymond Harris, MD, as director of the Department of Medicine’s Division of Nephrology and Hypertension in the Vanderbilt University School of Medicine effective July 1.

New research by Vanderbilt nephrologists highlights potential barriers that may prevent black Americans from being screened for kidney disease.

Vanderbilt’s Division of Nephrology and Hypertension has received a five-year, $5 million federal grant to provide core research services in the fight against kidney disease.